Recruiting nowPhase 1
Pharmacogenetics of Response to GLP1R Agonists
Updated 2026-07-27 · NCT05071898See eligibility →
Treatment
Semaglutide Pen Injector [Ozempic] clinical trials
Active studies that list Semaglutide Pen Injector [Ozempic] as an intervention or treatment.
3active studies
2recruiting now
1countries represented
1largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 4
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
Updated 2025-03-13 · NCT04873050See eligibility →
Opening soonPhase 2
Semaglutide in Auto-HSCT
Updated 2024-06-10 · NCT06449625See eligibility →
Related treatments
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.